HBV
Los inhibidores del VHB son compuestos diseñados para atacar e inhibir varias etapas del ciclo de vida del virus de la hepatitis B (VHB). Estos inhibidores pueden interferir con la replicación viral, el ensamblaje o la liberación, reduciendo así la carga viral y ayudando a manejar las infecciones crónicas por VHB. La investigación sobre inhibidores del VHB es crucial para desarrollar terapias antivirales efectivas que prevengan enfermedades hepáticas y cánceres asociados con el VHB. En CymitQuimica, ofrecemos una gama de inhibidores del VHB para apoyar su investigación en virología, desarrollo de medicamentos antivirales y gestión de enfermedades infecciosas.
Se han encontrado 176 productos de "HBV"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Entecavir
CAS:<p>Entecavir (SQ34676), a guanosine analogue, treats chronic HBV; may cause hepatitis B flares, not clear liver injury.</p>Fórmula:C12H15N5O3Pureza:99.14% - >99.99%Forma y color:White To Off-White/Yellow Crystalline PowderPeso molecular:277.28Catalpol
CAS:<p>Catalpol (Catalpinoside) is an iridoid glycoside with neuroprotective, anti-inflammatory, and anti-hepatitis virus effects.</p>Fórmula:C15H22O10Pureza:98.08% - 99.84%Forma y color:PowderPeso molecular:362.33Telbivudine
CAS:<p>Telbivudine (NV 02B) is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor.</p>Fórmula:C10H14N2O5Pureza:99.39% - 99.81%Forma y color:White E Crystal PowderPeso molecular:242.23Burfiralimab
CAS:<p>Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins and can be used to study rheumatoid arthritis.</p>Pureza:90%Forma y color:LiquidAntazoline hydrochloride
CAS:<p>Antazoline hydrochloride (Phenazoline hydrochloride), a first-generation antihistamine, can bind to the histamine H1 receptor and block the action of endogenous</p>Fórmula:C17H19N3·HClPureza:98% - 99.53%Forma y color:White Or Almost White Crystalline PowderPeso molecular:301.82Entecavir monohydrate
CAS:<p>Entecavir monohydrate (BMS-200475) is a selective inhibitor of the replication of the hepatitis B virus (HBV). It, a new deoxyguanine nucleoside analog.</p>Fórmula:C12H15N5O3·H2OPureza:99.73% - >99.99%Forma y color:White Crystalline PowderPeso molecular:295.3Metacavir
CAS:<p>Metacavir, a reverse transcriptase inhibitor, is used potentially for the treatment of HBV infection.</p>Fórmula:C11H15N5O3Pureza:>99.99% - >99.99%Forma y color:SolidPeso molecular:265.27Osalmid
CAS:<p>Osalmid (Oxaphenamide) is a choleretic drug, inhibits ribonucleotide reductase activity by targeting ribonucleotide reductase small subunit M2 (RRM2).</p>Fórmula:C13H11NO3Pureza:99.08% - 99.6%Forma y color:White CrystalPeso molecular:229.23GLP-26
CAS:<p>GLP-26, a CAM, blocks HBV by disrupting RNA encapsidation, reducing cccDNA >90% at 1μM, IC50=3nM in Hep AD38.</p>Fórmula:C19H17F2N3O3Pureza:98.62%Forma y color:SolidPeso molecular:373.35Inarigivir soproxil
CAS:<p>Inarigivir soproxil (SB9200) boosts innate immunity, combats HCV 1a/1b (EC50: 2.2/1.0 μM).</p>Fórmula:C25H34N7O13PSPureza:98.35%Forma y color:SolidPeso molecular:703.62Doxorubicin hydrochloride
CAS:<p>Doxorubicin hydrochloride (Adriamycin) belongs to the anthracycline class of antibiotics and is an inhibitor of human DNA topoisomerase I/II (IC50=0.8/2.67 μM).</p>Fórmula:C27H29NO11·HClPureza:98% - 99.52%Forma y color:Orange-Red At Neutral Phs And Violet Blue Over Ph 9 (Ntp 1992)Peso molecular:579.99NVR 3-778
CAS:<p>NVR 3-778 is a first-in-Class and oral bioavailable HBV CAM belonging to the SBA class It has anti-HBV activity.</p>Fórmula:C18H16F4N2O4SPureza:99.74%Forma y color:SolidPeso molecular:432.39Thiamine hydrochloride
CAS:<p>Thiamine hydrochloride (Vitamin B1) is an essential micronutrient and a cofactor for many central metabolic enzymes. High-Quality, Low-Cost!</p>Fórmula:C12H18Cl2N4OSPureza:99.63% - 99.96%Forma y color:White Crystal PowderPeso molecular:337.27Tenofovir
CAS:<p>Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B.</p>Fórmula:C9H14N5O4PPureza:98.69% - 99.92%Forma y color:White To Tan Solid Solid PowderPeso molecular:287.21Famciclovir
CAS:<p>Famciclovir (BRL 42810) inhibits Herpes virus DNA polymerase by mimicking nucleosides.</p>Fórmula:C14H19N5O4Pureza:99.85%Forma y color:Off-White PowderPeso molecular:321.33Morphothiadin
CAS:<p>Morphothiadin (GLS4) is a potent inhibitor on the replication of both wild-type and adefovir-resistant HBV (IC50 of 12 nM).</p>Fórmula:C21H22BrFN4O3SPureza:99.88%Forma y color:SolidPeso molecular:509.39AB-161
CAS:<p>AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research.</p>Fórmula:C21H21F2N3O5Forma y color:SolidPeso molecular:433.41Hepatitis B Virus Core (128-140)
CAS:HBV core protein found in nucleus and cytoplasm of infected hepatocytes; phosphorylation regulates nuclear presence by cell cycle.Fórmula:C66H103N17O17Pureza:98%Forma y color:SolidPeso molecular:1406.63Antiviral agent
CAS:<p>Antiviral agent is thiazolidin-4-one with anti-hepatitis B activity</p>Fórmula:C20H21N3O2S2Pureza:99.87%Forma y color:SoildPeso molecular:399.53Libevitug
<p>Libevitug is a humanized IgG1λ2 antibody targeting HBV, with HumanIgG1lambda2, Isotype Control as its corresponding isotype control.</p>Forma y color:Odour LiquidFirzacorvir
CAS:<p>Firzacorvir is a cyclic sulfamide compound that acts as an HBV core protein modulator and exhibits potent anti-HBV activity, with an EC50 value of < 1 μΜ.</p>Fórmula:C18H18ClFN6O3S2Forma y color:SolidPeso molecular:484.95Xalnesiran sodium
CAS:<p>Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B ( HBV )..</p>Fórmula:C664H814F17N231Na57O415P57S6Forma y color:SolidPeso molecular:22262.12Anti-virus Traditional Chinese Medicine Monomer Library
<p>A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.</p>Forma y color:LiquidElebsiran sodium
<p>Elebsiran sodium is an siRNA targeting hepatitis B and D virus infections [1].</p>Forma y color:Odour SolidKR019
<p>KR019 is a potent hepatitis B virus (HBV) capsid assembly modulator that demonstrates significant antiviral activity in HBV cells. It binds to the hydrophobic pocket at the core protein dimer-dimer interface, redirecting capsid assembly into genome-free capsids, thereby inhibiting viral replication.</p>Forma y color:Odour SolidJunceellolide C
CAS:<p>Junceellolide C: transcription inhibitor of cccDNA, curbs HBV DNA replication, EC50 of 5.19 & 3.52μM in HepAD38 cells, potent anti-HBV.</p>Fórmula:C26H33ClO10Forma y color:SolidPeso molecular:540.99Elebsiran
CAS:<p>Elebsiran is an antiviral agent [1] .</p>Fórmula:C485H658F9N158O294P39S6Forma y color:SolidPeso molecular:14976.62Hepatitis b virus pre-s region (120-145)
CAS:<p>Hepatitis B Virus Pre-S Region (120-145) is a preS2 peptide that effectively blocks the attachment of single-chain Fv fragment (scFv) or IgG to recombinant</p>Fórmula:C135H199N39O38SForma y color:SolidPeso molecular:3008.33HBV Seq1 aa:93-100
<p>HBV Seq1 aa:93-100 is a hepatitis B virus (HBV) core antigen 93-100 peptide fragment [1] .</p>Fórmula:C42H79N13O10SForma y color:SolidPeso molecular:958.22FNC-TP
CAS:<p>FNC-TP, an active FNC form, is a strong NRTI with anti-HIV, HBV, HCV effects.</p>Fórmula:C9H14FN6O13P3Forma y color:SolidPeso molecular:526.163'-DMTr-dG(iBu)
CAS:<p>'3'-DMTr-dG(iBu) is a nucleoside used in antiviral research and to combat Alzheimer's and other tauopathies.</p>Fórmula:C44H54N7O8PForma y color:SolidPeso molecular:839.92Tuvirumab
CAS:<p>Tuvirumab, a human IgG1 monoclonal antibody, targets HBsAg with high affinity (K=3.6 nM) for chronic hepatitis B research.</p>Forma y color:LiquidBulevirtide
CAS:<p>Bulevirtide (Myrcludex B) inhibits HBV/HDV entry into hepatocytes, treating chronic hepatitis D.</p>Fórmula:C248H355N65O72Pureza:98%Forma y color:SolidPeso molecular:5398.86Anti-Viral Compound Library
<p>A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;</p>Forma y color:Odour SolidHBV-IN-40
<p>HBV-IN-40 (Compound 11826096), with an IC50 of 0.7 µM, serves as a potent HBV inhibitor and exhibits antiviral activity [1].</p>Fórmula:C29H55Cl4N11Pureza:98%Forma y color:SolidPeso molecular:699.63Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside
CAS:<p>Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside (Compound 1), a lignan with anti-HBV activity, exhibits selectivity by targeting the HBV surface</p>Fórmula:C26H34O10Pureza:98%Forma y color:SolidPeso molecular:506.54HBV-IN-36
<p>HBV-IN-36 (also known as compound 42) is a hepatitis B virus (HBV) inhibitor with an IC50 of 2 μM, exhibiting anti-HBV activity characterized by an EC50 of 0.58</p>Fórmula:C21H18ClFN4O2Pureza:98%Forma y color:SolidPeso molecular:412.84HBV-IN-35
<p>Compound HBV-IN-35 (Compound 88) serves as an HBV inhibitor and exhibits anti-HBV activity in both mouse and human hepatocytes with EC50 values of 100 nM and</p>Fórmula:C22H23F5N4OPureza:98%Forma y color:SolidPeso molecular:454.44Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside
CAS:<p>Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside serves as an anti-hepatitis B virus (anti-HBV) agent, effectively inhibiting the secretion of HBV</p>Fórmula:C25H32O10Pureza:98%Forma y color:SolidPeso molecular:492.52HBV-IN-37
CAS:<p>HBV-IN-37, an HBV inhibitor with 10 μM EC50, may treat hepatitis B.</p>Fórmula:C23H22ClN3O2SPureza:98%Forma y color:SolidPeso molecular:439.96Destruxin B2
CAS:<p>Destruxin B2, found in M. anisopliae, has antiviral, insecticidal properties, inhibits HBsAg (IC50=1.3 μM), and is toxic to Sf9 cells (ECIS50=92 μM).</p>Fórmula:C29H49N5O7Forma y color:SolidPeso molecular:579.739Angeloylgomisin P
CAS:<p>Angeloylgomisin P is a useful organic compound for research related to life sciences. The catalog number is T124224 and the CAS number is 77881-08-4.</p>Fórmula:C28H34O9Forma y color:SolidPeso molecular:514.571BAY38-7690
CAS:<p>BAY38-7690, a hepatitis B virus inhibitor, may have potential for future therapeutic regimens to combat chronic HBV infection.</p>Fórmula:C19H16ClF2N3O2Forma y color:SolidPeso molecular:391.8HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
<p>Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide.</p>Forma y color:Lyophilized PowderPeso molecular:The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result.(Rac)-Tenofovir-d6
CAS:<p>(Rac)-Tenofovir-d6 is a deuterium-labelled tracer isotope . (Rac)-Tenofovir is a nucleoside reverse transcriptase inhibitor HIV and chronic hepatitis B.</p>Fórmula:C9H8D6N5O4PForma y color:SolidPeso molecular:293.25HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi)
<p>Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide.</p>Forma y color:Lyophilized PowderPeso molecular:The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result.Torcitabine
CAS:<p>Torcitabine is useful against the hepatitis B virus.</p>Fórmula:C9H13N3O4Forma y color:SolidPeso molecular:227.22HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
<p>Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide.</p>Forma y color:Lyophilized PowderPeso molecular:The protein has a predicted MW of 258 kDa. Due to glycosylation, the protein migrates to 260-265 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.Bicyclol
CAS:<p>Bicyclol is an oral anti-hepatitis drug, decreasing ALT/AST levels by 50% and inhibiting HBV/HCV, boosting efficacy with interferon/lamivudine/adefovir.</p>Fórmula:C19H18O9Pureza:99.64% - 99.85%Forma y color:SolidPeso molecular:390.34Vebicorvir
CAS:<p>Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor, has demonstrated effective antiviral activity.</p>Fórmula:C19H12F3N3O4S2Pureza:99.51% - 99.64%Forma y color:SolidPeso molecular:467.44Adefovir dipivoxil
CAS:<p>Adefovir dipivoxil (GS 0840) is a dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against</p>Fórmula:C20H32N5O8PPureza:98% - 99.80%Forma y color:It Has Broad-Spectrum Antiviral ActivityPeso molecular:501.47Isoscopoletin
CAS:<p>Isoscopoletin (7-Methoxyesculetin) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one.</p>Fórmula:C10H8O4Pureza:98.01% - 99.76%Forma y color:SolidPeso molecular:192.174,5-Dicaffeoylquinic acid
CAS:<p>1.</p>Fórmula:C25H24O12Pureza:98.86% - ≥95%Forma y color:SolidPeso molecular:516.45AB-423
CAS:<p>AB-423 is an inhibitor of HBV capsid assembly, and potently inhibits HBV replication (EC50/EC90: 0.08-0.27 μM/0.33-1.32 μM in cells).</p>Fórmula:C17H17F3N2O3SPureza:99.72% - 99.89%Forma y color:SolidPeso molecular:386.39Tenofovir Disoproxil Fumarate
CAS:Tenofovir Disoproxil Fumarate (GS-1278 Disoproxil Fumarate) is a pro-drug, a nucleoside reverse transcriptase inhibitor analog of adenosine.Fórmula:C19H30N5O10P·C4H4O4Pureza:98.60% - 99.02%Forma y color:White To Pink CrystallinePeso molecular:635.51Alisol F
CAS:<p>Alisol F is a natural product from Alisma plantago-aquatica Linn and has many activities.</p>Fórmula:C30H48O5Pureza:98.74% - 99.89%Forma y color:SolidPeso molecular:488.7RO6889678
CAS:RO6889678 is HBV inhibitor with a complex ADME profile.Fórmula:C21H20ClFN4O5SPureza:98.72%Forma y color:SolidPeso molecular:494.92Lamivudine salicylate
CAS:<p>Lamivudine salicylate, an oral NRTI, combats HIV 1/2 and HBV, and reaches the central nervous system.</p>Fórmula:C15H17N3O6SForma y color:SolidPeso molecular:367.38Cetylpyridinium Chloride
CAS:<p>Cetylpyridinium Chloride (Hexadecylpyridinium Chloride) is a cationic quaternary ammonium compound used as oropharyngeal antiseptic.</p>Fórmula:C21H38N·ClPureza:99.00% - 99.79%Forma y color:White Solid PowderPeso molecular:339.99Azvudine
CAS:<p>Azvudine (FNC) is a powerful NRTI effective against HIV, HBV, HCV, and resistant strains.</p>Fórmula:C9H11FN6O4Pureza:99.76% - >99.99%Forma y color:SolidPeso molecular:286.22Clevudine
CAS:<p>Clevudine (Levovir) fights HBV, blocks viral DNA synthesis, and has a long half-life reducing relapse risk after treatment.</p>Fórmula:C10H13FN2O5Pureza:99.88% - 99.97%Forma y color:SolidPeso molecular:260.22OSS_128167
CAS:<p>OSS_128167 (SIRT6-IN-1) is a specific SIRT6 inhibitor, and for SIRT6(IC50=89 μM), SIRT1(IC50=1578 μM) and SIRT2(IC50=751 μM).</p>Fórmula:C19H14N2O6Pureza:97.47% - 98.6%Forma y color:SolidPeso molecular:366.32Osthole
CAS:<p>Osthole (Osthol), a potential inhibitor of histamine H1 receptor, has been shown to stimulate osteoblast proliferation and differentiation.</p>Fórmula:C15H16O3Pureza:99.93% - 99.96%Forma y color:Fine White PowderPeso molecular:244.29Tizoxanide
CAS:<p>Tizoxanide (Desacetyl-nitazoxanide) is a metabolite of lamivudine.</p>Fórmula:C10H7N3O4SPureza:98.89% - 99.28%Forma y color:SolidPeso molecular:265.25Merimepodib
CAS:<p>Merimepodib (VX-497) is a novel noncompetitive inhibitor of Inosine monophosphate dehydrogenase(IMPDH).</p>Fórmula:C23H24N4O6Pureza:98.77% - 99.31%Forma y color:SolidPeso molecular:452.46Punicalin
CAS:<p>Punicalin: anti-inflammatory, antioxidative, anti-hepatotoxic, inhibits HIV-1 reverse transcriptase with an IC50 of 0.14 µM.</p>Fórmula:C34H22O22Pureza:97.72% - 99.95%Forma y color:SolidPeso molecular:782.53RO8191
CAS:<p>RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor.</p>Fórmula:C14H5F6N5OPureza:98% - 98.85%Forma y color:SolidPeso molecular:373.21Punicalagin
CAS:<p>Punicalagin, an ellagitannin in pomegranates, has antioxidant, anti-inflammatory, anticancer properties, and combats heart issues from high-fat diets.</p>Fórmula:C48H28O30Pureza:98% - 99.7%Forma y color:White Crystalline PowderPeso molecular:1084.72Lamivudine
CAS:<p>Lamivudine (BCH-189) is a reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring.</p>Fórmula:C8H11N3O3SPureza:99.56% - >99.99%Forma y color:White Crystalline PowderPeso molecular:229.26Adefovir
CAS:<p>Adefovir: acyclic nucleoside phosphonate, reverse transcriptase inhibitor for hepatitis B and herpes treatment.</p>Fórmula:C8H12N5O4PPureza:99.56%Forma y color:White To Off-White PowderPeso molecular:273.19RG7834
CAS:<p>RG7834 (RO 7020322) is an oral HBV inhibitor targeting HBsAg, HBeAg, and DNA; IC50s: 2.8, 2.6, 3.2 nM in dHepaRG cells.</p>Fórmula:C22H27NO6Pureza:98.00% - 99.87%Forma y color:SolidPeso molecular:401.454-Hydroxyacetophenone
CAS:<p>4-Hydroxyacetophenone (4-Acetylphenol) is a potent xanthine oxidase inhibitor.</p>Fórmula:C8H8O2Pureza:99.94%Forma y color:SolidPeso molecular:136.15Pseudolaric Acid B
CAS:<p>Pseudolaric acid B, a natural diterpenoid compound, is isolated from Pseudolarix kaempferi.</p>Fórmula:C23H28O8Pureza:98.91% - 99.84%Forma y color:SolidPeso molecular:432.46Isochlorogenic acid A
CAS:<p>Isochlorogenic acid A (3,5-Dicaffeoylquinic acid), a natural phenolic acid, exhibits antioxidant and anti-inflammatory properties.</p>Fórmula:C25H24O12Pureza:98.31% - 99.53%Forma y color:Grey To Yellow Crystalline SolidPeso molecular:516.45Inarigivir ammonium
CAS:<p>Inarigivir ammonium, an antiviral dinucleotide, lowers HBV DNA and activates innate immunity via RIG-I agonism.</p>Fórmula:C20H29N8O10PSPureza:99.91%Forma y color:SolidPeso molecular:604.53Chamaechromone
CAS:<p>Chamaechromone is a natural product isolated from the roots of Stellera chamaejasme L.. Chamaechromone has anti-HBV and insecticidal activity.</p>Fórmula:C30H22O10Pureza:99.44%Forma y color:SolidPeso molecular:542.49Tenofovir Disoproxil
CAS:<p>Tenofovir Disoproxil (GS 4331) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.</p>Fórmula:C19H30N5O10PPureza:99.17%Forma y color:SolidPeso molecular:519.44AT-130
CAS:<p>AT-130: Strong HBV inhibitor (IC50 0.13 μM), low toxicity in HepAD38, hinders RNA packaging.</p>Fórmula:C22H22BrN3O5Pureza:97.81%Forma y color:SolidPeso molecular:488.33Paederoside
CAS:<p>Paederoside deters beetles, isolated from aphids, and inhibits tumor-promotion in Epstein-Barr virus.</p>Fórmula:C18H22O11SPureza:97.81% - 99.9%Forma y color:SolidPeso molecular:446.43JNJ-632
CAS:<p>JNJ-632 is a hepatitis B virus (HBV) capsid assembly modulator.</p>Fórmula:C18H19FN2O4SPureza:99.17%Forma y color:SolidPeso molecular:378.42Bifendate
CAS:<p>Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.</p>Fórmula:C20H18O10Pureza:99.72%Forma y color:SolidPeso molecular:418.35Swertianolin
CAS:<p>Swertianolin: Chemotaxonomic marker, hepatoprotective, anti-acetylcholinesterase, scavenges radicals.</p>Fórmula:C20H20O11Pureza:98.71% - 99.77%Forma y color:SolidPeso molecular:436.37Bay 41-4109 racemate
CAS:<p>BAY 41-4109 racemate is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.</p>Fórmula:C18H13ClF3N3O2Pureza:98.49%Forma y color:SolidPeso molecular:395.76Vonafexor
CAS:<p>Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects</p>Fórmula:C19H15Cl3N2O5SPureza:98.74%Forma y color:SolidPeso molecular:489.76Vesatolimod
CAS:<p>Vesatolimod (GS-9620) is an effective and specific orally active agonist of Toll-like receptor 7.</p>Fórmula:C22H30N6O2Pureza:97.46% - 99.03%Forma y color:SolidPeso molecular:410.51Besifovir
CAS:<p>Besifovir 是由 LB80380 转化而来的一种 LB80380 母体药物，进一步代谢为其活性形式 LB80317。LB80380 是抗乙型肝炎病毒的抗病毒药物。</p>Fórmula:C10H14N5O4PPureza:≥95%Forma y color:SolidPeso molecular:299.22Doxorubicin
CAS:<p>Doxorubicin (Adriamycin) is a Topoisomerase II (Top2) inhibitor with antineoplastic activity.</p>Fórmula:C27H29NO11Pureza:99.31%Forma y color:Red Crystalline Solid SolidPeso molecular:543.52Oxethazaine
CAS:<p>Oxethazaine (Oxetacaine), a topical anesthetic, is used to prevent acid-induced esophageal pain.</p>Fórmula:C28H41N3O3Pureza:99.875% - 99.94%Forma y color:Physical Description White Powder (Ntp 1992)Peso molecular:467.64ccc_R08
CAS:<p>ccc_R08 is an HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg. ccc_R08 may be investigated in HBV infections.</p>Fórmula:C22H19ClO6Pureza:99.45% - 99.86%Forma y color:SoildPeso molecular:414.84Libivirumab
CAS:<p>Libivirumab: Humanized anti-HBV antibody; neutralizes HBsAg, HBeAg with IC50s of 35, 130 ng/mL.</p>Forma y color:LiquidExbivirumab
CAS:<p>Exbivirumab is an anti-hepatitis B virus monoclonal antibody (anti-HBV mAb) that amplifies the antiviral effects of hepatitis B immunoglobulin (HBIG) [1].</p>Forma y color:LiquidLenvervimab
CAS:<p>Lenvervimab (GC1102) is a recombinant human IgG1-type hepatitis B immunoglobulin designed for the research of hepatitis B virus infection [1] [2].</p>Forma y color:LiquidHBV-IN-43
CAS:<p>HBV-IN-43 (compound 5832) serves as a potent inhibitor of HBV [1].</p>Fórmula:C22H12F4N4OForma y color:SolidPeso molecular:424.35Oleana-2,12-dien-28-oic acid
CAS:<p>Oleana-2,12-dien-28-oic acid inhibits HBV, blocking HBsAg/HBeAg and DNA replication in HepG2.2.15, used in hepatitis B research.</p>Fórmula:C30H46O2Pureza:98%Forma y color:SoildPeso molecular:438.69Ibandronic acid
CAS:<p>Ibandronic acid (Bonviva) is a third-generation amino-bisphosphonate with anti-resorptive and anti-hypercalcemic activities.</p>Fórmula:C9H23NO7P2Pureza:94.84%Forma y color:White Semi-SolidPeso molecular:319.23(S)-Tenofovir
CAS:<p>(S)-Tenofovir ((S)-PMPA) is the less active S-enantiomer of Tenofovir which is a nucleotide reverse transcriptase inhibitor.</p>Fórmula:C9H14N5O4PPureza:99.9%Forma y color:SolidPeso molecular:287.21Canocapavir
CAS:<p>Canocapavir (ZM-H1505R) is an HBV coat protein modulator with antiviral activity for the treatment of hepatitis B virus.</p>Fórmula:C27H21BrFN5O3Pureza:98.4% - 98.40%Forma y color:SolidPeso molecular:562.39HBV-IN-7
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 5 nM).</p>Fórmula:C18H17ClFN3O5S2Forma y color:SolidPeso molecular:473.93PPT
CAS:<p>PPT is a modulator of water-heme interactions of CYP2C9d and CYP125A1 in low-spin P450 complexes.</p>Fórmula:C11H13N3Pureza:98%Forma y color:SolidPeso molecular:187.24DVR-23
CAS:<p>DVR-23 is a potent inhibitor of HBV virus.</p>Fórmula:C17H17F3N2O3SForma y color:SolidPeso molecular:386.39BAY39-5493
CAS:<p>BAY39-5493 is a hepatitis B virus inhibitor and possess antiviral activity in vitro and in vivo.</p>Fórmula:C17H15ClFN3O2SForma y color:SolidPeso molecular:379.84LP10
CAS:<p>LP10 is a reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1 and a Potent type II inhibitor of Trypanosoma cruzi CYP51.</p>Fórmula:C24H28N4O2Forma y color:SolidPeso molecular:404.5Rolicyprine
CAS:<p>Rolicyprine is an antidepressant.</p>Fórmula:C14H16N2O2Pureza:98%Forma y color:SolidPeso molecular:244.29trans-ccc_R08
CAS:<p>trans-ccc_R08: potent cccDNA inhibitor, IC50 0.08 µM, may help research HBV.</p>Fórmula:C22H19ClO6Forma y color:SolidPeso molecular:414.84HBV-IN-29
CAS:<p>HBV-IN-29 (ex8), a flavone derivative, inhibits cccDNA in HBV research.</p>Fórmula:C22H19ClO6Forma y color:SolidPeso molecular:414.84KKJ00626
CAS:<p>KKJ00626, an inhibitor of HBV virus, inhibits HBV replication in transfected Huh7 cells.</p>Fórmula:C7H8N4SPureza:98%Forma y color:SolidPeso molecular:180.23HBV-IN-19
CAS:<p>HBV-IN19 suppresses HBV, cutting HBsAg output, useful for chronic HBV study.</p>Fórmula:C24H30N2O6Forma y color:SolidPeso molecular:442.5HBV-IN-25
CAS:<p>HBV-IN-25: oral HBV cccDNA reducer, anti-HBeAg, anti-HBV (IC50: 0.58/1.15 μM), soluble (>452 μg/mL), non-toxic.</p>Fórmula:C18H14ClNO4Forma y color:SolidPeso molecular:343.76Selgantolimod
CAS:<p>Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection.</p>Fórmula:C14H20FN5OPureza:98%Forma y color:SolidPeso molecular:293.34Inarigivir
CAS:<p>Inarigivir (ORI-9020) is a dinucleotide that can significantly reduce liver HBV DNA.</p>Fórmula:C20H26N7O10PSPureza:98%Forma y color:SolidPeso molecular:587.5Alamifovir
CAS:<p>Alamifovir: HBV-specific antiviral, purine analog prodrug; active against wild-type/lamivudine-resistant HBV; inhibits DNA initiation/packaging.</p>Fórmula:C19H20F6N5O5PSForma y color:SolidPeso molecular:575.42(5S,8R)-HBV-IN-10
CAS:<p>'(5S,8R)-HBV-IN-10 is an EC50 0.1-1 μM HBsAg inhibitor, isomer of compound 6 from patent WO2021204258A1.</p>Fórmula:C23H24FN7OForma y color:SolidPeso molecular:433.48Helioxanthin derivative 5-4-2
CAS:<p>Helioxanthin derivative 5-4-2 （Helioxanthin 5-4-2） is an analogue of helioxanthin that shows anti-HBV activity in vitro and can be used to study HBV.</p>Fórmula:C20H13NO5Pureza:99.91% - 99.92%Forma y color:SolidPeso molecular:347.32Fosclevudine alafenamide
CAS:<p>Fosclevudine alafenamide (Compound EIDD-02173) is an antiviral agent that acts against HBV (EC50: 1.71 μM).</p>Fórmula:C22H29FN3O9PForma y color:SolidPeso molecular:529.45Taribavirin hydrochloride
CAS:<p>Taribavirin HCl: oral drug targeting HCV in liver, spares red blood cells, aims to reduce anemia risk.</p>Fórmula:C8H14ClN5O4Pureza:98%Forma y color:SolidPeso molecular:279.68Helioxanthin 8-1
CAS:<p>Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM.</p>Fórmula:C20H12N2O6Pureza:98%Forma y color:SolidPeso molecular:376.32(-)-5′-Noraristeromycin
CAS:<p>(-)-5′-Noraristeromycin is an antiviral agent.</p>Fórmula:C10H13N5O3Forma y color:SolidPeso molecular:251.24RIG-1 modulator 1
CAS:<p>RIG-1 modulator 1 is useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV.</p>Fórmula:C14H17N5OS2Pureza:98%Forma y color:SolidPeso molecular:335.45BA38017
CAS:<p>BA38017 is a potent assembly modulator of HBV core protein that inhibits the replication of HBV (EC50 = 0.20 μM) [1].</p>Fórmula:C15H11ClFNO3Forma y color:SolidPeso molecular:307.7BA-53038B
CAS:<p>BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM).</p>Fórmula:C14H16ClNOForma y color:SolidPeso molecular:249.74Bay 41-4109 (less active enantiomer)
CAS:<p>Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent HBV inhibitor (IC50: 53 nM).</p>Fórmula:C18H13ClF3N3O2Pureza:98%Forma y color:SolidPeso molecular:395.76Bentysrepinine
CAS:<p>Bentysrepinine, a novel anti-HBV agent, inhibits DNA-HBV and cccDNA activities for the treatment of hepatitis B virus (HBV)-infected hepatitis.</p>Fórmula:C29H35N3O4Pureza:98%Forma y color:SolidPeso molecular:489.61HBV-IN-10
CAS:<p>HBV-IN-10, an isomer of compound 6, inhibits HBsAg with EC50 between 0.1-1 μM (Patent WO2021204258A1).</p>Fórmula:C23H24FN7OForma y color:SolidPeso molecular:433.48NVP018
CAS:<p>NVP018 (BC 556) inhibits HBV, HCV, HIV-1 replication, barely affects drug transporters, and resists HCV/HIV-1 resistance development.</p>Fórmula:C45H62FN5O11Forma y color:SolidPeso molecular:868DVR-01
CAS:<p>DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.</p>Fórmula:C20H23ClN2O3SPureza:99.95%Forma y color:SolidPeso molecular:406.93Clevudine triphosphate
CAS:<p>Clevudine triphosphate is a TTP analog that is able to inhibit protein priming independently of the deoxynucleoside triphosphate substrate.</p>Fórmula:C10H16FN2O14P3Pureza:98%Forma y color:SolidPeso molecular:500.16Lagociclovir
CAS:<p>Lagociclovir (MIV-210), a nucleoside analogue antiviral, treats HBV by inhibiting its replication in liver cancer cells.</p>Fórmula:C10H12FN5O3Pureza:99.18% - 99.33%Forma y color:SolidPeso molecular:269.23Bay 41-4109
CAS:<p>BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV)(IC50 : 53 nM).</p>Fórmula:C18H13ClF3N3O2Forma y color:SolidPeso molecular:395.76HBV-IN-9
CAS:<p>HBV-IN-9 inhibits HBsAg (IC50: 10 nM) and HBV DNA replication (IC50: 0.15 nM) per WO2018001952A1.</p>Fórmula:C22H24FN7OForma y color:SolidPeso molecular:421.47Taribavirin
CAS:<p>Taribavirin: oral drug targeting HCV in liver, spares RBCs to reduce risk of anemia.</p>Fórmula:C8H13N5O4Pureza:98%Forma y color:SolidPeso molecular:243.22HBV-IN-6
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 44 nM).</p>Fórmula:C23H21ClFN3O5S2Forma y color:SolidPeso molecular:538.01Vidarabine phosphate
CAS:<p>Vidarabine phosphate is an adenosine monophosphate analog.</p>Fórmula:C10H14N5O7PPureza:99.75%Forma y color:White Crystalline PowderPeso molecular:347.22HBV-IN-32
CAS:<p>HBV-IN-32 is a strong cccDNA inhibitor with an IC50 of 0.14 µM against HBsAg, also halting cell growth.</p>Fórmula:C22H19ClO5SForma y color:SolidPeso molecular:430.9L-Fd4A
CAS:<p>L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.</p>Fórmula:C10H10FN5O2Forma y color:SolidPeso molecular:251.22AB-506
CAS:<p>AB-506: Oral HBV replication blocker, targets core protein, hinders pgRNA encapsidation, for CHB study.</p>Fórmula:C21H18ClF2N5O3Forma y color:SolidPeso molecular:461.85cis-ccc_R08
CAS:<p>cis-ccc_R08 infection . cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor .</p>Fórmula:C22H19ClO6Forma y color:SolidPeso molecular:414.84Besifovir PM
<p>Besifovir PM (LB80331 PM) is an analogue of Besifovir, a novel orally available acyclic nucleotide phosphonate for the treatment of chronic hepatitis B</p>Fórmula:C11H15N5OPureza:98.48% - 99.90%Forma y color:SoildPeso molecular:233.27Isothiafludine
CAS:<p>Isothiafludine is a HBV virus inhibitor that dramatically reduces the HBV DNA level in cells.</p>Fórmula:C18H18FN3OS2Pureza:99.71%Forma y color:SolidPeso molecular:375.48Bersacapavir
CAS:<p>Bersacapavir (JNJ-56136379) is an in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.</p>Fórmula:C16H14F4N4O3SPureza:98.53%Forma y color:SolidPeso molecular:418.37Tivicilovir
CAS:<p>Tivicilovir (AM188) is a hepatitis B virus inhibitor. tiviclovir is a guanine-related acyclic 2'-deoxyguanine analogue with anti-herpesvirus activity.</p>Fórmula:C9H13N5O3Pureza:99.94%Forma y color:SolidPeso molecular:239.23Pradefovir
CAS:<p>Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.</p>Fórmula:C17H19ClN5O4PPureza:97.50%Forma y color:SolidPeso molecular:423.79HBV-IN-8
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 287.9 nM).</p>Fórmula:C21H25ClFN5O5S2Forma y color:SolidPeso molecular:546.04HBF-0259
CAS:HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.Fórmula:C16H12Cl2FN5Pureza:98.07% - 99.42%Forma y color:SolidPeso molecular:364.2HBV-IN-13
CAS:<p>HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg).</p>Fórmula:C22H25NO7Forma y color:SolidPeso molecular:415.44HEC72702
CAS:<p>HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.</p>Fórmula:C24H26BrFN4O5SForma y color:SolidPeso molecular:581.45HBV-IN-17
CAS:<p>HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM).</p>Fórmula:C17H15F6N5O2Forma y color:SolidPeso molecular:435.32Oxynitidine
CAS:<p>Oxynitidine, an HBV inhibitor (ID50 = 30.8 µg/mL), effectively suppresses HBV DNA replication and may be utilized in viral infection research [1].</p>Fórmula:C21H17NO5Pureza:98%Forma y color:SolidPeso molecular:363.36HBV-IN-41
CAS:<p>HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].</p>Fórmula:C18H19ClFN5O3Pureza:98%Forma y color:SolidPeso molecular:407.83Emtricitabine triphosphate tetrasodium salt
CAS:<p>Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleoside</p>Fórmula:C8H9FN3Na4O12P3SPureza:98%Forma y color:SolidPeso molecular:575.11Tobevibart
CAS:<p>Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].</p>Pureza:98%Forma y color:LiquidIR415
CAS:<p>IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx</p>Fórmula:C13H14F2N4SPureza:99.85%Forma y color:SolidPeso molecular:296.34Valtorcitabine dihydrochloride
CAS:<p>Valtorcitabine dihydrochloride, a DNA polymerase inhibitor, is used potentially for the treatment of HBV infection.</p>Fórmula:C14H24Cl2N4O5Forma y color:SolidPeso molecular:399.27Besifovir Dipivoxil maleate
CAS:<p>Besifovir Dipivoxil maleate, an oral HBV prodrug (LB80380), suppresses HBV DNA in naive and lamivudine-resistant CHB cases.</p>Fórmula:C22H34N5O8PPureza:98%Forma y color:SolidPeso molecular:527.51HBV-IN-30
CAS:<p>HBV-IN-30, a flavone derivative, inhibits cccDNA in HBV research.</p>Fórmula:C22H18BrClO6Forma y color:SolidPeso molecular:493.73SHR5133
CAS:<p>SHR5133 is a potent, orally active regulator of HBV capsid assembly that reduces HBV DNA (EC50: 26.6 nM).</p>Fórmula:C19H18F4N6O2Forma y color:SolidPeso molecular:438.38AB-836
CAS:<p>AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.</p>Fórmula:C20H15F3N4O2Forma y color:SolidPeso molecular:400.35Lagociclovir valactate
CAS:<p>Lagociclovir valactate is a prodrug of Lagociclovir . Lagociclovir valactate is an orally active anti- HBV agent [1] .</p>Fórmula:C18H25FN6O6Forma y color:SolidPeso molecular:440.43Linvencorvir
CAS:<p>Linvencorvir is a hepatitis B virus (HBV) core protein variant modifier used to treat chronic HBV infection.</p>Fórmula:C29H35FN6O5SPureza:99.9% - 99.9%Forma y color:SolidPeso molecular:598.69Tenofovir amibufenamide
CAS:<p>Tenofovir amibufenamide (HS-10234) 是一种 Tenofovir 前药，是一种具有口服活性的抗病毒化合物。Tenofovir amibufenamide 对乙型肝炎病毒 (HBV)具有抑制作用，可用于慢性乙型肝炎 (CHB) 研究。</p>Fórmula:C22H31N6O5PPureza:99.19% - 99.87%Forma y color:SolidPeso molecular:490.49HBV-IN-24
<p>HBV-IN-24 inhibits HBV DNA, HBsAg, HBeAg (EC50: 0.6, 0.6, 4.6 nM), and has antiviral properties with neurotoxicity mitigation.</p>Fórmula:C23H27NO6Forma y color:SolidPeso molecular:413.46HBV/HDV-IN-3
CAS:<p>HBV/HDV-IN-3 (Compd 1) acts as a dual inhibitor for HBV and HDV, demonstrating an efficacy (EC 50) below 50 nM against HBV .</p>Fórmula:C28H27BrF3N5O3Forma y color:SolidPeso molecular:618.44SAG-524
CAS:<p>SAG-524 is a powerful oral small molecule that inhibits HBV viral replication. In HepG2.2.15 cells, SAG-524 reduced HBV-DNA and HbsAg levels in the supernatant with IC₅₀ values of 0.92 nM and 1.4 nM, respectively [1].</p>Fórmula:C30H32ClN5O4SForma y color:SolidPeso molecular:594.12HBV/HDV-IN-2
CAS:<p>HBV/HDV-IN-2 (Compd 143) functions as an inhibitor for HBV, HDV, and PD-1/PD-L1, demonstrating an EC 50 of 35 nM in T cell activation.</p>Fórmula:C38H44ClN7O5Forma y color:SolidPeso molecular:714.25TLR8 agonist 4
<p>TLR8 agonist 4 inhibits wild-type and lamivudine/entecavir-resistant HBV; IC50: 0.15 μM and 0.10 μM.</p>Fórmula:C28H27N5O5SForma y color:SolidPeso molecular:545.61HBV-IN-12
CAS:<p>HBV-IN-12: strong HBsAg & HBV DNA inhibitor; EC50 0.001-0.05 μM & 0.001-0.02 μM respectively. (WO2021204252A1)</p>Fórmula:C23H27NO8Forma y color:SolidPeso molecular:445.46HBV-IN-11
CAS:<p>HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM).</p>Fórmula:C21H24ClNO6Forma y color:SolidPeso molecular:421.87HBV-IN-18
<p>HBV-IN-18 (Compound 3) is an HBV capsid assembly modulator (CpAM) (EC50: 2790 nM).</p>Fórmula:C17H15F6N5O2Forma y color:SolidPeso molecular:435.32HBV-IN-48
CAS:<p>HBV-IN-48, an HBV inhibitor, exhibits potent antiviral activity against HBV in HepDE19 cells, demonstrated by its EC 50 value of 0.005 μM. Additionally, it effectively reduces serum HBV DNA levels in mouse models of HBV infection.</p>Fórmula:C22H15F4N3O3Forma y color:SolidPeso molecular:445.37FNC-TP trisodium
<p>FNC-TP trisodium, active intracellular FNC form, inhibits NRTI, fights HIV, HBV, and HCV.</p>Fórmula:C9H11FN6Na3O13P3Forma y color:SolidPeso molecular:592.11HBV-IN-31
CAS:<p>HBV-IN-31: strong cccDNA inhibitor, anti-HBV, IC50=0.13 µM HBsAg, hampers cell growth.</p>Fórmula:C23H18ClNO6Forma y color:SolidPeso molecular:439.85HBV-IN-20
<p>HBV-IN-20 is a potent, orally active HBV inhibitor (EC50: 0.46 μM). HBV-IN-20 is a classical type II CpAM (core protein assembly regulator).</p>Forma y color:SolidALG-000184
CAS:<p>ALG-000184, a prodrug of the potent HBV capsid assembly modulator ALG-001075, shows potential for use in HBV infection research.</p>Fórmula:C23H20FN4Na2O8PForma y color:SolidPeso molecular:576.379HBV-IN-19 TFA
CAS:<p>HBV-IN19 TFA suppresses HBsAg, hampers HBV infection, and aids in HBV research.</p>Fórmula:C26H31F3N2O8Forma y color:SolidPeso molecular:556.53HBV-IN-34
CAS:<p>HBV-IN-34 (compound 17i) is a potent inhibitor of HBsAg production, demonstrating remarkable in vitro anti-HBV efficacy with EC50 values of 0.018 μM for HBV DNA</p>Fórmula:C21H19F2N7Pureza:98%Forma y color:SolidPeso molecular:407.42Ref: TM-T79469
Producto descatalogadoHBV-IN-38
CAS:<p>HBV-IN-38 (Example 193), an HBV DNA inhibitor with an EC50 value of ≤100 nM, serves as a research tool for investigating viral infections [1].</p>Fórmula:C18H16F3N5O4S2Pureza:98%Forma y color:SolidPeso molecular:487.48Yhhu6669
CAS:<p>Yhhu6669 is an anti-HBV agent that suppresses viral DNA and replication by promoting DNA-free capsid assembly, effectively reducing HBV DNA and HBcAg levels in</p>Fórmula:C29H28ClFN6O3Pureza:98%Forma y color:SolidPeso molecular:563.02Ref: TM-T78756
Producto descatalogado
